My NAD+ (nicotinamide adenine dinucleotide) level is 89, which is low; how should I manage it?

Management of Low NAD+ Level (89)

Increase your NAD+ levels through niacin (vitamin B3) supplementation, starting with 16 mg/day for males or 14 mg/day for females as baseline dietary intake, with consideration for higher therapeutic doses of 15-20 mg/day of nicotinic acid or up to 300 mg/day of nicotinamide if deficiency symptoms are present. 1

Understanding Your NAD+ Level

Your NAD+ level of 89 requires context for proper interpretation, as reference ranges vary by laboratory and measurement method. However, the evidence clearly demonstrates that NAD+ levels decline with age and can be therapeutically increased through supplementation. 1

• NAD+ is the active metabolic form derived from niacin (vitamin B3), serving as a coenzyme for over 400 enzymes involved in energy metabolism, DNA repair, and cellular function 1
• Age-related decline is well-documented, with significant decreases in cellular NAD+ levels occurring in men (P = 0.001; r -0.706) and women (P = 0.01; r -0.537) as they age 1
• Low NAD+ levels contribute to mitochondrial dysfunction, resulting in a "cellular energy crisis" that can manifest as muscle weakness, fatigue, and neurological symptoms 1

Recommended Supplementation Strategy

First-Line Approach: Dietary Niacin Optimization

• Ensure adequate baseline intake of 16 mg/day for males >14 years or 14 mg/day for females >14 years through diet 1
• Food sources with highest niacin content include fortified packaged foods, meat, poultry, red fish (tuna, salmon), nuts, legumes, and organ meats 1
• Niacin can be synthesized from tryptophan in the liver (67 mg tryptophan produces 1 mg nicotinamide), requiring adequate intake of thiamine, riboflavin, and pyridoxine for this conversion 1

Therapeutic Supplementation Options

If deficiency symptoms are present (muscle weakness, fatigue, anxiety, irritability, depression, gait disturbances): 1

• Nicotinic acid: 15-20 mg/day is effective for treating traditional pellagra and NAD+ deficiency 1
• Nicotinamide: 300 mg/day can be used therapeutically, with an upper limit of approximately 900 mg/day for adults (12.5 mg/kg body weight/day) 1
• Avoid exceeding 10 mg/day of free nicotinic acid for routine supplementation due to flushing side effects that can occur at 30 mg/day 1

Emerging NAD+ Precursor Supplementation

Recent clinical trials support the use of direct NAD+ precursors: 2, 3, 4

• Nicotinamide mononucleotide (NMN): 250-900 mg/day has been shown safe and effective in raising blood NAD+ levels in healthy middle-aged adults 2, 5
• Dose-dependent response observed, with significant variability between individuals (coefficient of variation 29.2-113.3%) 2
• Clinical benefits include improved walking distance on 6-minute walk test and quality of life scores when NAD+ increases by 13.5-15.7 nmol/L 2
• Long-term supplementation (12 weeks) at 250 mg/day was well tolerated without adverse events and showed potential for reducing arterial stiffness 5

Clinical Monitoring and Safety

When to Measure NAD+ Levels

• Measurement is recommended if you have clinical symptoms including diarrhea, dermatitis, dementia (pellagra disease), or neuromuscular deficits 1
• Urinary metabolites (N-methyl-nicotinamide and N-methyl-2-pyridone-carboxamide) are the most reliable biomarkers of niacin status 1
• Blood NAD+ levels can be measured, though storing a sample and monitoring clinical response to supplementation may be more pragmatic 1

Safety Considerations

• Nicotinamide is better tolerated than nicotinic acid, with no flushing effects at therapeutic doses 1
• Common side effects of NAD+ supplementation include muscle pain, nervous disorders, fatigue, sleep disturbance, and headaches, though none present serious health risks 6
• Hepatotoxicity risk with nicotinic acid occurs at very high doses (around 3 g/day), far above therapeutic recommendations 1
• Monitor for improvement in symptoms such as muscle weakness, fatigue, anxiety, and cognitive function within 1-2 months 2, 7

Special Populations and Conditions

Increased NAD+ Requirements

• Elderly individuals have documented age-related NAD+ decline and may benefit from higher supplementation doses 1
• Pregnant women require 18 mg/day and lactating women 16 mg/day of niacin 1
• Patients with cardiovascular disease, particularly heart failure, may benefit from NAD+ supplementation to improve cardiac function (LVEF improvement demonstrated with 10 mg/day IV NAD+ in clinical trials) 7, 8

Risk Factors for Deficiency

• Malabsorption states including prolonged diarrhea, short bowel syndrome, or chronic alcoholism increase deficiency risk 1
• Carcinoid tumors and metabolic disorders affecting tryptophan absorption can cause secondary deficiency 1
• Long-term chemotherapy or radiation therapy increases NAD+ consumption through DNA damage 1

Practical Implementation

Start with dietary optimization ensuring adequate niacin-rich foods, then add nicotinamide 300 mg/day if symptomatic, or consider NMN 250-500 mg/day for direct NAD+ precursor supplementation with monitoring of clinical response over 8-12 weeks. 1, 2, 5